Efficacy of nivolumab/ipilimumab in patients with initial or late progression with nivolumab: Updated analysis of a tailored approach in advanced renal cell carcinoma (TITAN-RCC).

被引：24

作者：

Grimm, Marc-Oliver

Esteban, Emilio

Barthelemy, Philippe

Schmidinger, Manuela

Busch, Jonas

Valderrama, Begona P.

Schmitz, Marc

Schumacher, Ulrike

Baretton, Gustavo Bruno

Duran, Ignacio

de Velasco, Guillermo

Priou, Frank

Maroto-Rey, Pablo

Schinzari, Giovanni

Albiges, Laurence

机构：

[1] Univ Klinikum Jena, Dept Urol, Jena, Germany

[2] Hosp Univ Cent Asturias, Dept Med Oncol, Oviedo, Spain

[3] Inst Cancerol Strasbourg Europe, Strasbourg, France

[4] Med Univ Wien, Vienna Gen Hosp AKH, Dept Internal Med 1, Vienna, Austria

[5] Univ Hosp Charite Berlin, Dept Urol, Berlin, Germany

[6] Hosp Univ Virgen del Rocio, Dept Med Oncol, Seville, Spain

[7] Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Immunol, Dresden, Germany

[8] Univ Klinikum Jena, Ctr Clin Studies, Jena, Germany

[9] Tech Univ Dresden, Univ Klin Carl Gustav Carus, Inst Pathol, Dresden, Germany

[10] Hosp Univ Marques de Valdecilla, IDIVAL, Cantabria, Spain

[11] Hosp 12 Octubre, Dept Oncol, Madrid, Spain

[12] CHD Vendee Hop Les Oudairies, La Roche Sur Yon, France

[13] Hosp Santa Creu & Sant Pau, Dept Med Oncol, Barcelona, Spain

[14] Univ Cattolica Sacro Cuore, Policlin Univ A Gemelli, Rome, Italy

[15] Univ Paris Sud, Dept Canc Med, Gustave Roussy Canc Campus, Villejuif, France

来源：

关键词：

D O I：

10.1200/JCO.2021.39.15_suppl.4576

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4576

引用

页数：3